IL10 and inflammatory bowel disease: Other studies have also suggested a role for ERβ in modulating intestinal inflammation [11], in particular the publication by Looijer-van Langen et al. that demonstrates decreased ERβ expression in both human IBD patients, and in rodent models of IBD, including the IL-10−/− mouse and the HLA-B27 rat [44].